Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

NCT02756858 is registered in ClinicalTrials.gov with Anavex Life Sciences Corp. as lead sponsor.

NCT NCT02756858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02756858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
Anavex Life Sciences Corp.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2016
Completion date
November 30, 2020
Enrollment
21 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease